Journal
BLOOD
Volume 107, Issue 5, Pages 1864-1871Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2005-06-2600
Keywords
-
Categories
Funding
- NIGMS NIH HHS [GM 46732, R01 GM046732] Funding Source: Medline
Ask authors/readers for more resources
Ligand binding to the thrombopoietin receptor (TpoR) is thought to impose a dimeric receptor conformation(s) leading to hematopoietic stem cell renewal, megakaryocyte differentiation, and platelet formation. Unlike other cytokine receptors, such as the erythropoietin receptor, TpoR contains an amphipathic KWQFP motif at the junction between the transmembrane (TM) and cytoplasmic domains. We show here that a mutant TpoR (Delta 5TpoR), where this sequence was deleted, is constitutively active. In the absence of ligand, Delta 5TpoR activates Jak2, TYk2, STAT5, and mitogen-activated protein (MAP) kinase, but does not appear to induce STAT3 phosphorylation. Delta 5TpoR induces hematopoietic myeloid differentiation in the absence of Tpo. In the presence of Tpo, the Delta 5TpoR mutant appears to enhance erythroid differentiation when compared with the Tpo-activated wild-type TpoR. Strikingly, individual substitution of K507 or W508 to alanine also induces constitutive TpoR activation, indicating that the K and W residues within the amphipathic KWQFP motif are crucial for maintaining the unliganded receptor inactive. These residues may be targets for activating mutations in humans. Such a motif may exist in other receptors to prevent ligand-independent activation and to allow signaling via multiple flexible interfaces.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available